Status:
TERMINATED
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Type 2 Diabetes
Dyslipidemia
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
PHASE3
Brief Summary
Double-blind, randomized placebo-controlled study in type 2 diabetes and dyslipidemic patients.Patients will be randomized to one of four treatment arms for 16 weeks: placebo, fenofibrate, metformin, ...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus and dyslipidemia.
Exclusion
- Type 1 diabetes.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00362765
Start Date
October 1 2006
End Date
July 1 2007
Last Update
August 13 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 2
Turku, Finland
2
Site 3
Dublin, Ireland
3
Site 1
Pisa, Italy